Mumbai: KEM hospital gets DCGI's nod to start COVID-19 vaccine trials

Days after the Oxford vaccine trial was halted due to suspected adverse reactions reported in a participant, KEM hospital officials said that the Drug Controller General of India (DCGI) gave them a green signal to resume the trials on Wednesday. However, the hospital needs the final nod from the ethics committee, which will meet...